Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lieselot van Erven

Showing results (71-80 of 120) with videos related to

Pageof 12
Sort By:
Heart Rhythm|November 19, 2011
Implantable cardioverter-defibrillator longevity under clinical circumstances: an analysis according to device type, generation, and manufacturerJoep Thijssen, C Jan Willem Borleffs, Johannes B van Rees, et al.
Journal of Cardiovascular Electrophysiology|July 30, 2005
Long-term follow-up of cardiac resynchronization therapy in patients with end-stage heart failureSander G Molhoek, Jeroen J Bax, Gabe B Bleeker, et al.
Journal of the American College of Cardiology|December 20, 2005
Left ventricular dyssynchrony predicts right ventricular remodeling after cardiac resynchronization therapyGabe B Bleeker, Martin J Schalij, Petros Nihoyannopoulos, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 11, 2003
Quantification of left ventricular mechanical dyssynchrony by conductance catheter in heart failure patientsPaul Steendijk, Sven A F Tulner, Jan J Schreuder, et al.
Pacing and Clinical Electrophysiology : PACE|July 4, 2009
Left ventricular ejection fraction as criterion for implantation of an implantable cardioverter-defibrillator in heart failure patients undergoing surgical left ventricular reconstructionSjoerd A Mollema, Patrick Klein, Jogien Heersche, et al.
Pacing and Clinical Electrophysiology : PACE|February 23, 2012
Update on small-diameter implantable cardioverter-defibrillator leads performanceJohannes B van Rees, Guido H van Welsenes, C Jan Willem Borleffs, et al.
Pacing and Clinical Electrophysiology : PACE|May 12, 2010
Recurrent implantable cardioverter-defibrillator replacement is associated with an increasing risk of pocket-related complicationsC Jan Willem Borleffs, Joep Thijssen, Mihály K de Bie, et al.
European Journal of Cardiovascular Nursing|March 31, 2026
Efficacy and Workload Implications of the Triage-HF™ Algorithm in a Nurse- and Allied Professional-Led Heart Failure Care PathwayBert A C Zwaenepoel, Ugur Aslan, Bas Kirchhof, et al.
Heart Rhythm|November 22, 2017
Implantable cardioverter-defibrillator therapy in hypertrophic cardiomyopathy: A SIMPLE substudyMate Vamos, Jeff S Healey, Jia Wang, et al.
Circulation. Arrhythmia and Electrophysiology|October 8, 2009
Risk of failure of transvenous implantable cardioverter-defibrillator leadsC Jan Willem Borleffs, Lieselot van Erven, Rutger J van Bommel, et al.
Pageof 12

Showing results (71-80 of 120) with videos related to

Sort By:
Pageof 12
Heart Rhythm|November 19, 2011
Implantable cardioverter-defibrillator longevity under clinical circumstances: an analysis according to device type, generation, and manufacturerJoep Thijssen, C Jan Willem Borleffs, Johannes B van Rees, et al.
Journal of Cardiovascular Electrophysiology|July 30, 2005
Long-term follow-up of cardiac resynchronization therapy in patients with end-stage heart failureSander G Molhoek, Jeroen J Bax, Gabe B Bleeker, et al.
Journal of the American College of Cardiology|December 20, 2005
Left ventricular dyssynchrony predicts right ventricular remodeling after cardiac resynchronization therapyGabe B Bleeker, Martin J Schalij, Petros Nihoyannopoulos, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 11, 2003
Quantification of left ventricular mechanical dyssynchrony by conductance catheter in heart failure patientsPaul Steendijk, Sven A F Tulner, Jan J Schreuder, et al.
Pacing and Clinical Electrophysiology : PACE|July 4, 2009
Left ventricular ejection fraction as criterion for implantation of an implantable cardioverter-defibrillator in heart failure patients undergoing surgical left ventricular reconstructionSjoerd A Mollema, Patrick Klein, Jogien Heersche, et al.
Pacing and Clinical Electrophysiology : PACE|February 23, 2012
Update on small-diameter implantable cardioverter-defibrillator leads performanceJohannes B van Rees, Guido H van Welsenes, C Jan Willem Borleffs, et al.
Pacing and Clinical Electrophysiology : PACE|May 12, 2010
Recurrent implantable cardioverter-defibrillator replacement is associated with an increasing risk of pocket-related complicationsC Jan Willem Borleffs, Joep Thijssen, Mihály K de Bie, et al.
European Journal of Cardiovascular Nursing|March 31, 2026
Efficacy and Workload Implications of the Triage-HF™ Algorithm in a Nurse- and Allied Professional-Led Heart Failure Care PathwayBert A C Zwaenepoel, Ugur Aslan, Bas Kirchhof, et al.
Heart Rhythm|November 22, 2017
Implantable cardioverter-defibrillator therapy in hypertrophic cardiomyopathy: A SIMPLE substudyMate Vamos, Jeff S Healey, Jia Wang, et al.
Circulation. Arrhythmia and Electrophysiology|October 8, 2009
Risk of failure of transvenous implantable cardioverter-defibrillator leadsC Jan Willem Borleffs, Lieselot van Erven, Rutger J van Bommel, et al.
Pageof 12